{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:53:36Z","timestamp":1791500016077,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0507700"],"award-info":[{"award-number":["2023ZD0507700"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD1800500"],"award-info":[{"award-number":["2025ZD1800500"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473761"],"award-info":[{"award-number":["82473761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277110"],"award-info":[{"award-number":["22277110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421243"],"award-info":[{"award-number":["252300421243"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242301420005"],"award-info":[{"award-number":["242301420005"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tips.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:17:15Z","timestamp":1790857035000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic programming via lysine-specific demethylase 1 regulates responses to immune checkpoint blockade"],"prefix":"10.1016","author":[{"given":"Xiaoshuang","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-643X","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.09.006_bb0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tips.2026.09.006_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2026.09.006_bb0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12929-023-00952-0","article-title":"LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy","volume":"30","author":"Mamun","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.tips.2026.09.006_bb0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tips.2025.01.006","article-title":"Leveraging non-enzymatic functions of LSD1 for novel therapeutics","volume":"46","author":"Song","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.09.006_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","article-title":"LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade","volume":"174","author":"Sheng","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41388-018-0451-5","article-title":"Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade","volume":"38","author":"Qin","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2026.09.006_bb0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/0008-5472.CAN-24-3239","article-title":"LSD1 inhibition induces MHC-I and dendritic cell activation to promote antitumor immunity in head and neck squamous cell carcinoma","volume":"86","author":"Chakraborty","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2026.09.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/JCI189044","article-title":"Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppression","volume":"136","author":"Kuprasertkul","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.09.006_bb0060","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1038\/s41467-026-70984-1","article-title":"LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC","volume":"17","author":"Machida","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.09.006_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tips.2026.09.006_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-025-02311-z","article-title":"LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAF mutant colorectal cancer","volume":"24","author":"Ladaika","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tips.2026.09.006_bb0075","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1038\/s41467-024-48607-4","article-title":"Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells","volume":"15","author":"Qiu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.09.006_bb0080","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1038\/s41467-024-51500-9","article-title":"LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness","volume":"15","author":"Pallavicini","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.09.006_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41586-025-09440-x","article-title":"Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells","volume":"649","author":"Hor","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.09.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-025-01378-4","article-title":"Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy","volume":"23","author":"Chen","year":"2026","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0095","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtho.2022.05.014","article-title":"Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC","volume":"17","author":"Nguyen","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tips.2026.09.006_bb0100","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41588-024-01880-x","article-title":"Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells","volume":"56","author":"Jang","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2026.09.006_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41368-025-00363-x","article-title":"Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression","volume":"17","author":"Chakraborty","year":"2025","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.tips.2026.09.006_bb0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41419-024-07275-4","article-title":"KDM1A epigenetically enhances RAD51 expression to suppress the STING-associated anti-tumor immunity in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.09.006_bb0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1541-7786.MCR-21-0310","article-title":"Inhibition of LSD1 attenuates oral cancer development and promotes therapeutic efficacy of immune checkpoint blockade and YAP\/TAZ inhibition","volume":"20","author":"Alhousami","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.tips.2026.09.006_bb0125","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.gendis.2022.11.002","article-title":"Inhibition of lysine-specific demethylase 1 (LSD1) prevented tumor growth and metastasis by downregulating PD-L1 expression in lung adenocarcinoma","volume":"10","author":"He","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.tips.2026.09.006_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-021-03556-4","article-title":"LSD1 silencing contributes to enhanced efficacy of anti-CD47\/PD-L1 immunotherapy in cervical cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.09.006_bb0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41423-023-01118-6","article-title":"Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex","volume":"21","author":"Li","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"LAG-3, TIM-3, and TIGIT: distinct functions in immune regulation","volume":"57","author":"Joller","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2026.09.006_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189351","article-title":"Vista as a context-dependent immune checkpoint: implications for tumor immunity and autoimmune pathogenesis","volume":"1880","author":"Niu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tips.2026.09.006_bb0150","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI131375","article-title":"Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity","volume":"130","author":"Xiong","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.09.006_bb0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3389\/fimmu.2020.01228","article-title":"Targeting nuclear LSD1 to reprogram cancer cells and reinvigorate exhausted T cells via a novel LSD1-EOMES switch","volume":"11","author":"Tu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2026.01.004","article-title":"Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes","volume":"59","author":"Grassmann","year":"2026","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2026.09.006_bb0165","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41587-025-02856-w","article-title":"Integrated epigenetic and genetic programming of primary human T cells","volume":"44","author":"Goudy","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2026.09.006_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.09.006_bb0175","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tips.2026.09.006_bb0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41419-025-07951-z","article-title":"Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation","volume":"16","author":"Staehle","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.09.006_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10428194.2021.2012667","article-title":"Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed\/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes","volume":"63","author":"Roboz","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.tips.2026.09.006_bb0190","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/bloodadvances.2025017575","article-title":"Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia","volume":"10","author":"Gill","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.tips.2026.09.006_bb0195","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-020-0765-5","article-title":"Inhibition of LSD1 in MDS progenitors restores differentiation of CD141Hi conventional dendritic cells","volume":"34","author":"Srivastava","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.tips.2026.09.006_bb0200","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jtho.2019.06.021","article-title":"Phase I, open-label, dose-escalation study of the safety, pharmacokinetics, pharmacodynamics, and efficacy of GSK2879552 in relapsed\/refractory SCLC","volume":"14","author":"Bauer","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.tips.2026.09.006_bb0205","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molcel.2007.06.039","article-title":"Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1","volume":"27","author":"Saleque","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1535-7163.MCT-16-0471","article-title":"A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML cells","volume":"16","author":"Ishikawa","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2026.09.006_bb0215","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41386-018-0300-9","article-title":"T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice","volume":"44","author":"Matsuda","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2026.09.006_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114522","article-title":"Design, synthesis, and structure-activity relationship of TAK-418 and its derivatives as a novel series of LSD1 inhibitors with lowered risk of hematological side effects","volume":"239","author":"Hattori","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2026.09.006_bb0225","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-22-1128","article-title":"Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T-cell killing","volume":"28","author":"Hiatt","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tips.2026.09.006_bb0230","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.3390\/jcm13113120","article-title":"Landscape and treatment options of shapeshifting small cell lung cancer","volume":"13","author":"Gu","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tips.2026.09.006_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1214675","article-title":"Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential","volume":"14","author":"Bao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0240","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1158\/0008-5472.CAN-25-0998","article-title":"TNG260 is a small-molecule CoREST inhibitor that sensitizes STK11-mutant tumors to anti-PD-1 immunotherapy","volume":"85","author":"Ahronian","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2026.09.006_bb0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/13543776.2025.2468792","article-title":"JBI-802: the first orally available LSD1\/HDAC6 dual inhibitor to enter clinical trials","volume":"35","author":"Zhang","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.tips.2026.09.006_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1664443","article-title":"Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies","volume":"16","author":"Catani","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113477","article-title":"E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC","volume":"42","author":"Tang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2026.09.006_bb0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193162","article-title":"USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I","volume":"136","author":"Liu","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.09.006_bb0265","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2025.09.011","article-title":"TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors","volume":"44","author":"Herbrich","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0270","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.celrep.2013.09.018","article-title":"Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells","volume":"5","author":"Zhang","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2026.09.006_bb0280","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.18632\/aging.102887","article-title":"The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes","volume":"12","author":"Cuyas","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.tips.2026.09.006_bb0285","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1038\/s41467-022-31998-7","article-title":"Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.09.006_bb0290","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41590-025-02219-2","article-title":"Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity","volume":"26","author":"Wijesinghe","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tips.2026.09.006_bb0295","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.devcel.2025.02.016","article-title":"Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi\/MEKi-resistant melanoma","volume":"60","author":"Li","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0300","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2024.04.006","article-title":"Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities","volume":"45","author":"Konen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.09.006_bb0305","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.09.006_bb0310","first-page":"43","article-title":"Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction","volume":"4","author":"Qiu","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.tips.2026.09.006_bb0315","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2425812122","article-title":"Discovery of an LSD1 PROTAC degrader","volume":"122","author":"Hosseini","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561472600235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561472600235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:31:08Z","timestamp":1791498668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561472600235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S016561472600235X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.006","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic programming via lysine-specific demethylase 1 regulates responses to immune checkpoint blockade","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}